• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童非HLA相合骨髓移植后白细胞和网织红细胞计数随访对早期移植物失败的预测

Follow-up of leucocyte and reticulocyte counts for the prediction of early graft failure after non-HLA-identical BMT in children.

作者信息

Gerritsen E J, Stam E D, Van den Berg H, Haraldsson A, Van Tol M J, Vossen J M

机构信息

Department of Paediatrics, Leiden University Hospital, The Netherlands.

出版信息

Bone Marrow Transplant. 1996 May;17(5):781-7.

PMID:8733698
Abstract

Allogeneic BMT using a non-genotypically HLA-identical donor may be curative for children suffering from lethal haematological diseases, who lack a genotypically HLA-identical donor. Unfortunately, graft failures are often seen, especially after T cell depletion of the graft. We studied whether untimely decreased counts of leucocytes and reticulocytes in peripheral blood might predict graft failure at an early stage. Fifty-five recipients of a non-genotypically HLA-identical BM graft were included in the study; data from these children were compared with those of 77 recipients of a genotypically HLA-identical BM graft. Time-related reference values of peripheral blood leucocyte and reticulocyte counts were established in graft recipients with proven donor-origin recovery after BMT. Graft failure after nonHLA-identical BMT was observed in 16 out of 55 children (29%) and after HLA-identical BMT in one out of 77 (1.3%). With respect to early graft failure, the predictive value of granulocyte numbers falling below the lower limit of the reference values and a rapid decline of reticulocyte numbers after their appearance in peripheral blood was 100% (95% confidence intervals of 83-100% and of 80-100%, respectively). Early immunosuppressive intervention was applied in six patients and was successful in three of them.

摘要

对于患有致命血液疾病且缺乏基因分型HLA匹配供体的儿童,使用非基因分型HLA匹配供体进行异基因骨髓移植可能具有治愈效果。不幸的是,移植失败情况经常出现,尤其是在对移植物进行T细胞去除后。我们研究了外周血中白细胞和网织红细胞计数过早下降是否可能在早期预测移植失败。55名接受非基因分型HLA匹配骨髓移植的受者被纳入研究;将这些儿童的数据与77名接受基因分型HLA匹配骨髓移植的受者的数据进行比较。在骨髓移植后已证实供体来源恢复的移植受者中建立外周血白细胞和网织红细胞计数的时间相关参考值。55名儿童中有16名(29%)在接受非HLA匹配骨髓移植后出现移植失败,77名中有1名(1.3%)在接受HLA匹配骨髓移植后出现移植失败。关于早期移植失败,粒细胞数量低于参考值下限以及网织红细胞在外周血中出现后数量迅速下降的预测价值为100%(95%置信区间分别为83 - 100%和80 - 100%)。6名患者接受了早期免疫抑制干预,其中3名成功。

相似文献

1
Follow-up of leucocyte and reticulocyte counts for the prediction of early graft failure after non-HLA-identical BMT in children.儿童非HLA相合骨髓移植后白细胞和网织红细胞计数随访对早期移植物失败的预测
Bone Marrow Transplant. 1996 May;17(5):781-7.
2
Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children.
Bone Marrow Transplant. 1996 Aug;18(2):377-82.
3
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.来自基因分型 HLA 不相同的相关供体的 CD6+ T 细胞耗竭的异基因骨髓移植。
Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.
4
Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.对于接受来自 HLA 同型同胞的异基因脐血移植的β地中海贫血患儿,供体/受体混合嵌合体不能预测移植失败。
Haematologica. 2008 Dec;93(12):1859-67. doi: 10.3324/haematol.13248. Epub 2008 Oct 22.
5
[Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].[莱顿大学医学中心30年骨髓移植评估:人类白细胞抗原配型相合的骨髓移植治疗重症再生障碍性贫血患儿的良好近期预后]
Ned Tijdschr Geneeskd. 2002 Aug 17;146(33):1542-6.
6
Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.源自脐带血、骨髓或外周血的造血干细胞移植:异质性风险人群的单中心配对分析
Klin Padiatr. 2004 Nov-Dec;216(6):356-63. doi: 10.1055/s-2004-832357.
7
Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts.根据白细胞计数对异基因骨髓移植后有因感染、出血或移植物衰竭而死亡风险的患者进行早期识别。
Bone Marrow Transplant. 1997 Feb;19(4):349-55. doi: 10.1038/sj.bmt.1700657.
8
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.异基因反应性以及抗受体特异性产生白细胞介素2的辅助性T淋巴细胞前体细胞频率对骨髓移植后异基因反应性的预测价值。
Dan Med Bull. 2002 May;49(2):89-108.
9
Unexpected late graft failure 9 months after HLA-identical bone marrow transplant (BMT) for chronic myeloid leukemia (CML): treatment with a second BMT.
Haematologica. 1998 Mar;83(3):285-7.
10
Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.严重再生障碍性贫血的骨髓移植:巴塞罗那医院诊所的经验
Haematologica. 1999 Jan;84(1):26-31.